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Background: Mental problems are common in nursing homes, and the medical answer to these condi-
tions is largely pharmacological. However, frail elderly people are particularly vulnerable to
psychotropic-related adverse effects. This study documents the current use of psychotropics in Flemish
nursing homes, and examines the relation to fall risk.
Methods: This is a cohort study in 651 nursing home residents in 53 nursing homes in Flanders, Belgium.
The use of antidepressants, anxiolytics, sedatives, and antipsychotics was registered from the patients’
medication charts. The incidence of subsequent falls was registered for a period of 6 months.
Results: In this cohort, 74.8% of nursing home residents without dementia used at least one psychotropic
drug; almost 20% used an antipsychotic, approximately 40% used one or more antidepressants; and
approximately 60% used one or more benzodiazepines or benzodiazepine-related drugs. The most
prescribed antipsychotic was risperidone (35.1%); the most common benzodiazepine was lormetazepam
(54.8%); and the most frequent antidepressants were citalopram/escitalopram (38.9%) and trazodone
(24.9%). The use of psychotropics was mostly chronic. Falls were registered in 24.1% of participants; they
were mainly associated with antidepressant use (odds ratio 1.38), and especially with trazodone (odds
ratio 1,94).
Conclusion: Despite recommendations against chronic use and a growing body of evidence showing the
risk of side effects, the use of psychotropic drugs currently is still alarmingly high in Flemish nursing
home residents without dementia. Strategies to optimize prescribing are discussed.
Copyright  2014, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. Open access under CC BY-NC-ND license.1. Introduction
Old age comes with a signiﬁcant chance of mental problems.
Major depressive disorder and dysthymia are frequent and have a
profound impact on quality of life and daily functioning.1,2 Anxiety
symptoms and more speciﬁcally generalized anxiety disorder are
highly prevalent, commonly occur together with affective disor-
ders, and are associated with considerable morbidity.3,4 Especiallyd Interdisciplinary Care, Fac-
ntwerp, Universiteitsplein 1,
Verhoeven).
linical Gerontology & Geriatrics. Pin old age, assessment and diagnosis of depression as well as
anxiety are difﬁcult tasks.2,5
Moreover, in institutionalized elderly people, with but also
without dementia, aggressive behavior, agitation, wandering, de-
lusions, and hallucinations are experienced as behavioral distur-
bances for which therapy is sought.6,7 Finally, sleeping problems
are common complaints in elderly people, so much the more in
nursing homes.8
The medical answer to these conditions traditionally is largely
pharmacological. Antidepressants,9 anxiolytics,10 hypnotics11 and
antipsychotics12 are commonly prescribed to nursing home resi-
dents. However, comorbidity, changes in metabolism and phar-
macokinetics, and polypharmacy make this population particularlyublished by Elsevier Taiwan LLC.Open access under CC BY-NC-ND license.
 
Table 1
Characteristics of study participants (n ¼ 651).
Mean age (SD; range) 84.05 years (7.14; 65e101)
Sex
Female 488 (75.0)
Male 163 (25.0)
Use of psychotropics
0 164 (25.2)
1 230 (35.4)
2 153 (23.5)
3 65 (10.0)
4 (max. 7) 39 (5.9)
Use of antidepressants
0 378 (58.0)
1 224 (34.4)
2 46 (7.1)
3 2 (0.3)
4 1 (0.2)
Use of anxiolytics/hypnotics
0 277 (42.5)
1 307 (47.2)
2 60 (9.2)
3 7 (1.1)
Use of antipsychotics
0 536 (82.4)
1 10 (17.0)
2 4 (0.6)
Data are presented as n (%), unless otherwise indicated.
SD ¼ standard deviation.
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prescription of psychotropics is higher in institutionalized elderly
people than in others.13 All four classes of drugs are associated with
an increased risk of sedation, falls, and cognitive impairment.This
paper documents, quantitatively and qualitatively, the current
psychotropic drug prescribing patterns in healthy nursing home
residents without cognitive impairment in Belgium. Furthermore,
we relate the use of these psychotropics to the incidence of falls in
our cohort.
2. Methods
This study was part of a large study on respiratory tract in-
fections in 53 nursing homes in Flanders, Belgium.14 Healthy
volunteers aged >65 years (no upper age limit) who gave
informed consent were included. Exclusion criteria included
advanced chronic illness (e.g., unstable heart disease, chronic
obstructive pulmonary disease requiring the use of oxygen,
parenteral nutrition, and poorly controlled diabetes) and cogni-
tive impairment. The Mini-Mental State Examination was used to
measure cognitive impairment (cutoff 24/30); this test is, in our
country, part of the regular routine assessment for people living
in nursing homes. The use of psychotropics was registered from
the patients’ medication charts according to the Anatomical
Therapeutic Chemical Classiﬁcation System. We registered the
following drugs: antipsychotics (N05A), anxiolytics (N05B), hyp-
notics and sedatives (N05C) and antidepressants (N06A). Regis-
tration was performed cross-sectionally at the beginning of the
study; in addition, in a nonselective sample of 20% of all study
participants, drug use was registered a second time at the end of
the 6-month study period.
Fall incidence was registered by the nursing home staff on a
structured form, for a period of 6 months. A fall was deﬁned as
“unintentionally coming to rest on the ground, with or without
physical injury as a consequence”.
Descriptive analyses were performed using SPSS version 20.0
(SPSS Inc., Chicago, IL, USA). Odds ratios (ORs) for fall risk were
calculated in univariate logistic regressionmodels; furthermore, for
each class of drugs (antidepressants, antipsychotics, anxiolytics,
and antipsychotics), ORs were adjusted for concurrent use of drugs
of the other classes.
Ethical approval for this study was granted by the Medical
Research Ethics Committee, University Hospital of Antwerp, Wil-
rijk, Belgium. This approval was considered sufﬁcient by the
participating nursing homes e they were free but not obliged to
seek for ethical advice on participation with their own ethical
board. Every participating nursing home resident gave written
consent to participate in the study.
3. Results
The study cohort consisted of 651 nursing home residents; their
characteristics are shown in Table 1. Themale/female ratio (25/75%)
reﬂected the population in the sampled nursing homes. In this
cohort, three in four non-demented elderly people took at least one
psychotropic. At the end of the study period, the number of psy-
chotropic drugs was unchanged in most (73%) of an aselective
sample of 20% of study participants. In 14%, one or more psycho-
tropics were added, and in 13% the number of psychotropics had
diminished.
3.1. Antidepressants
Antidepressants were used by 42% of participants (Table 1); in
people taking a single antidepressant, 56.1% took selectiveserotonin reuptake inhibitors (SSRIs), 8.9% serotoninenoradrenalin
reuptake inhibitors (SNRIs), 6.3% tricyclic antidepressants (TCAs),
and 19.4% trazodone. Other drugs (9.3%) were mainly mianserine
and mirtazapine. Most prescribed substances were trazodone
(24.9%), citalopram (23.1%), escitalopram (15.8%), sertraline (13.9%),
paroxetine (9.2%), venlafaxine (8.1%), amitryptiline (6.6%), and
mirtazapine (6.6%). Most prescribed single antidepressants were
citalopram (19.8%), trazodone (19.4%), escitalopram (14.7%), ser-
traline (11.7%), and paroxetine (8.8%).3.2. Anxiolytics and hypnotics
Almost 60% of nursing home residents took benzodiazepines
and benzodiazepine-related drugs (zolpidem and zopiclone;
Table 1). Anxiolytics were used by 23.8% and sedatives by 40.3%.
Most prescribed drugs were lormetazepam (54.8%), lorazepam
(17.4%), zolpidem (15.2%), alprazolam (11.5%), temazepam (6.5%),
and bromazepam (5.4%). Flunitrazepam was used by 1.3% of
patients.3.3. Antipsychotics
Most prescribed antipsychotics were risperidone (35.1%), olan-
zapine (9.6%), ﬂupentixol (9.6%), haloperidol (7.9%), pipamperone
(7.9%), and melperone HCl (7.0%).3.4. Inﬂuence of age and sex
In this cohort, age had no inﬂuence on the use of antidepres-
sants, anxiolytics/hypnotics, or antipsychotics, or on the global use
of psychotropics.
Female residents were more likely to use psychotropics (77.0%
vs. 67.2%, p ¼ 0.02), and more speciﬁcally, they used more anxio-
lytics/sedatives (61.9% vs. 42.4%, p < 0.001). We observed no effect
of age or sex on the choice of speciﬁc type of drugwithin the class of
antidepressants, anxiolytics, and antipsychotics.
Table 2
Unadjusted and adjusted ORs for fall risk.
Unadjusted OR
(95% CI)
Signiﬁcance
level
Adjusteda OR
(95% CI)
Signiﬁcance
level
Antidepressants 1.70 (1.10e2.62) 0.02 1.68 (1.08e2.62) 0.02
Benzodiazepines 1.08 (0.70e1.66) 0.75 1.04 (0.67e1.63) 0.86
Antipsychotics 1.25 (0.74e2.13) 0.41 1.18 (0.69e2.03) 0.54
a Adjusted for use of the other classes, that is, for antidepressants: adjusted for
benzodiazepines and antipsychotics, etc.
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In our population, 24.1% of people had at least one fall in the
follow-up period of 6 months. Univariate ORs are shown. Table 2
shows univariate and adjusted ORs for use of antidepressants,
benzodiazepines, and antipsychotics. Adjusting ORs for use of the
other medication classes did not result in qualitative changes.
Neither sex nor age had a signiﬁcant effect on fall incidence in this
population [OR 1.25 (p ¼ 0.36) and 1.02 (p ¼ 0.21), respectively].
Antidepressant use was positively associated with risk of falls
(p ¼ 0.02); OR for fall risk with one drug was 1.38, and was 2.87
with two drugs. Patients taking trazodone alone or in combination
with other antidepressants fell more often than patients who did
not take trazodone (36% vs. 22.7%, OR ¼ 1.92, p ¼ 0,05). The ten-
dency to fall was greater in TCA users (OR¼ 1.73), but the difference
was not statistically signiﬁcant (p ¼ 0.37).
We observed no clear association between benzodiazepine use
and fall risk in our population (OR ¼ 1.08, p ¼ 0.75). No clear dif-
ference in fall risk between anxiolytics (N05B) and hypnotics and
sedatives (N05C) was found. We observed no clear association
between antipsychotics use and fall risk in our population
(OR ¼ 1.25, p ¼ 0.41). Within the group of antipsychotics, we found
a higher chance of falls in patients taking haloperidol (OR ¼ 4.27,
p ¼ 0.04), and a tendency in patients taking pipamperone
(OR ¼ 4.80, p ¼ 0.06). No such effect was found for risperidone,
olanzapine, melperone HCl, and ﬂupentixol.
4. Discussion
This study provides detailed information on current prescribing
practices for non-demented residents of nursing homes in Belgium.
In our cohort, three quarters of people used at least one psycho-
tropic drug; almost 20% used an antipsychotic; about 40% used one
or more antidepressants; and almost 60% used one or more ben-
zodiazepines or benzodiazepine-related drugs. Similar or even
higher rates have been found in other studies, although compari-
sons are hampered by the fact that most reports do not differentiate
between residents with and without dementia.7,15e17
The lack of clinical information, including the reasons for pre-
scription of psychotropics, and the fact that dosages were not
registered, is a limitation that should be considered when inter-
preting the ﬁndings of this study. Registration of drug use was
essentially cross-sectional, however, re-registration in an aselective
sample of 20% of participants at the end of the study showed that
the use of psychotropics was mostly long term, which is a common
ﬁnding in elderly people.18 Strengths of our study include the fact
that registration was done directly from the patients’ medication
charts in the nursing homes (not from the medical ﬁles in the
doctor’s ofﬁce), the clear deﬁnition of a fall, and the prospective
study design for fall registration.19
In Belgium, we have a mixed public and private health care
system. Long-term residential care is run by community social
services, private nonproﬁt corporations, or religious charities.
About 3000 rest/nursing homes are spread all over the country;
except for dementia, homes are not specialized in speciﬁc illnessesand accept residents with various medical illnesses. In Belgium,
every home is legally obliged to have a medical coordinator; this is
a general practitioner (GP) who coordinates quality initiatives, such
as development and use of a formulary. This medical coordinator is
also the GP for some of the residents, although most residents keep
their own GP. This means that a large number of different pre-
scribers are active in most nursing homes. These are usually inde-
pendent GPs who have their ownpractice andwho visit the nursing
homes periodically.20
The prevalence of antidepressant use is similar to other
studies.16 Evidence for effectiveness of antidepressants in elderly
homes is limited and shows a moderate response to treatment.9
Underuse as well as overuse have been described in this popu-
lation.21 A study in nursing homes in the USA showed a
discrepancy between prescriptions of antidepressants and the
presence or absence of depression diagnosis in medical charts.22
Similarly, in a subgroup of our study population, we obtained
some clinical information by means of the 36-Item Short Form
Health Survey (SF-36); these data have been reported else-
where.23 Interestingly, no consistent link was found between the
use of psychopharmacology and the items of the mental health
scale of this SF-36.23 Qualitative research indicates that the pre-
scription of antidepressants in elderly nursing home residents
commonly is not preceded by a thorough diagnostic process.24 A
study in Swedish nursing homes showed that SSRIs could be
successfully withdrawn in more than half of the patients on long-
term treatment.25
Despite recommendations against the use of benzodiazepines in
elderly people, they are still the most commonly used psychotro-
pics in this population. The prevalence of benzodiazepine use in our
study in non-dementia nursing home residents was even slightly
higher than in a similar registration in Belgium a few years earlier,
in a mixed dementia/non- dementia population.16 Discontinuation
of benzodiazepine use in elderly people often has a beneﬁcial effect
on psychomotor and cognitive functioning,26,27 and even limited
tailored interventions seem to be effective and safe in reducing the
use of these drugs.26 However, attitudes of both health care pro-
viders and patients seem to be a barrier to discontinuation of these
drugs.28
We were surprised by the ample use of antipsychotics in this
non-dementia population; however, similar data have been found
in other studies.7 It is not entirely clear why the prescription rate of
this class of medication is so high in patients without dementia.
Antipsychotics have an unfavorable safety proﬁle in this popula-
tion.29,30 A recent study in elderly nursing home residents has
shown that second-generation antipsychotics are commonly used
for off-label indications, including treatment of bipolar disorder,
depression, and psychotic symptoms; these indications are not al-
ways evidence based.31 Another study reviewing the indications for
antipsychotic prescribing in 693,000 nursing home residents,
stated that one in four patients had no appropriate indication; most
common inappropriate indications were impaired memory,
depression without psychotic features, and indifference to
surroundings.32
Within nursing homes, institutional characteristics may inﬂu-
ence prescribing practices and quality. The size of a nursing home,
private versus public setting, education level and number of staff-
ing, number of different prescribers, use of a medication manage-
ment system such as a formulary, and case mix of residents may be
correlated with prescribing practices. An earlier study on pre-
scribing in general in 76 nursing homes in Belgium unveiled that
prescription rate and prescription problems weremainly correlated
with polypathology and with a less-favorable resident/staff ratio;
number of prescribers and activity of the medical coordinator had a
smaller inﬂuence.20 As described in the methods section, our
V. Verhoeven et al. / Journal of Clinical Gerontology & Geriatrics 5 (2014) 53e5756sample consisted of relatively healthy nursing home residents
without advanced chronic illness and cognitive impairment e
medication use in our population is not representative for global
prescription practices in these nursing homes, but it can be ex-
pected that in residents with more pathology and with dementia,
prescription rate will be even higher.
Falls are a common health problem in nursing homes and risk
factors can be categorized as extrinsic (e.g., unsafe footwear or poor
lighting), intrinsic (e.g., vestibular problems or vision loss), and
behavioral.33 Psychotropic drugs are an independent intrinsic risk
factor for falls in elderly people.19,33
The risk estimates for falls associated with antidepressant use in
our study were similar to ORs from a recent meta-analysis34: 1.36
[95% conﬁdence interval (CI): 1.13e1.76] versus 1.38 in our study.
For neuroleptics and antipsychotics, the risk was comparable: 1.39
(95% CI: 0.94e2.0) versus 1.25 in our study, but for benzodiazepines
the risk appeared to be smaller in our cohort [1.41 (95% CI: 1.20e
1.71) versus 1.1 in our study]. Tolerance to side effects in chronic use
of benzodiazepines35 and the fact that our cohort was restricted to
non-dementia elderly people, might have had an inﬂuence on the
medication-associated risk. In general, the use of typical antipsy-
chotics, long-acting benzodiazepines, and TCAs is discouraged in
elderly people,15,36 and decreasing prescription rates of these drugs
is considered as a good trend in clinical practice. Furthermore,
SSRIs, SNRIs, and atypical antipsychotics recently have also been
shown to have a less-favorable safety proﬁle than initially
thought.30,37,38
However, recent observations show that the prescription rate of
psychotropics is increasing instead of decreasing in nursing
homes.15 It is not clear whether this is a result of better awareness
of mental problems. Stress in nursing home staff and logistic factors
(lower staff/patient ratio, and a higher number of patients living in
one room) seem to correlate with a higher use and/or inappropriate
use of these medications in most20,39,40 but not in all studies.41
Although nursing staff have been shown to express a preference
for non-drug interventions for psychosocial and behavioral prob-
lems,42 understafﬁng and time pressure may compromise the
adoption of ideals and values in practice,43 and favor the choice for
an easier, that is, pharmacological solution to some challenges. In
physicians, a high patient load may compromise judicious pre-
scribing.44 Furthermore, psychotropic marketing practices may
drive prescribing of these classes of drugs in physicians who lack
adequate, evidence-based training.45
The good news is that interventions to reduce inappropriate
drug use might be efﬁcient in this frail population, because people
in nursing homes can be reached as a group.46 There is moderate
evidence that interventions that reduce the use of psychotropic
medications, as a single intervention or as part of a multifactorial
intervention, are effective in reducing falls.33 Interventions that aim
at reducing the initiation of psychotropics if alternatives are
possible, may be another valuable strategy next to reducing exist-
ing prescriptions. Validated tools exist to assess appropriateness of
prescribing.47 Educating health care providers in geriatric psycho-
pharmacology can reduce the use of antipsychotics and benzodi-
azepines in nursing homes, without adversely affecting the
behavior and functioning of the residents.48 Better stafﬁng in
nursing homes has also been shown to reduce chronic use of
benzodiazepines.49
Education seems to be a key factor in improving prescribing
practices. Structural measures, such as organizing continuous ed-
ucation, allocation of educational time to relevant personnel, and
installing explicit routines for medication review, will need to be
taken in order to maximize the chances of success.50
In conclusion, the present study gives an oversight of howmany
and which psychotropics are used in Flemish nursing homes.Antidepressants were especially correlated with fall risk in our
population of institutionalized elderly people without dementia.
Despite recommendations against chronic use and a growing body
of evidence showing the risk of side effects, the use of psychotropic
drugs currently is still alarmingly high in nursing homes in our
country.Conﬂicts of interest
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